|
2026-03-19 |
2026-03-17 |
BMRN |
BIOMARIN PHARMACEUTICAL INC |
Hardy Alexander |
CEO, Dir |
F - Tax |
$56.05 |
-4,252 |
214.6K |
-2% |
-$238.3K |
| D |
2026-03-17 |
2026-03-13 |
BMRN |
BIOMARIN PHARMACEUTICAL INC |
Hardy Alexander |
CEO, Dir |
F - Tax |
$58.51 |
-2,941 |
156.4K |
-2% |
-$172.1K |
| D |
2026-03-17 |
2026-03-16 |
BMRN |
BIOMARIN PHARMACEUTICAL INC |
Hardy Alexander |
CEO, Dir |
A - Grant |
$0.00 |
+62.4K |
218.9K |
+40% |
$0 |
|
2025-12-02 |
2025-04-30 |
BMRN |
BIOMARIN PHARMACEUTICAL INC |
Hardy Alexander |
CEO, Dir |
A - Grant |
$54.14 |
+375 |
176.0K |
+0.2% |
+$20.3K |
|
2025-12-02 |
2025-12-01 |
BMRN |
BIOMARIN PHARMACEUTICAL INC |
Hardy Alexander |
CEO, Dir |
F - Tax |
$55.03 |
-16.6K |
159.4K |
-9% |
-$911.8K |
| D |
2025-03-18 |
2025-03-14 |
BMRN |
BIOMARIN PHARMACEUTICAL INC |
Hardy Alexander |
CEO, Dir |
F - Tax |
$69.44 |
-2,933 |
131.2K |
-2% |
-$203.7K |
| D |
2025-03-18 |
2025-03-17 |
BMRN |
BIOMARIN PHARMACEUTICAL INC |
Hardy Alexander |
CEO, Dir |
A - Grant |
$0.00 |
+44.4K |
175.6K |
+34% |
$0 |
|
2024-12-03 |
2024-11-29 |
BMRN |
BIOMARIN PHARMACEUTICAL INC |
Hardy Alexander |
CEO, Dir |
F - Tax |
$66.03 |
-14.3K |
134.2K |
-10% |
-$943.9K |
|
2024-12-03 |
2024-10-31 |
BMRN |
BIOMARIN PHARMACEUTICAL INC |
Hardy Alexander |
CEO, Dir |
A - Grant |
$56.01 |
+300 |
148.5K |
+0.2% |
+$16.8K |
| D |
2024-03-19 |
2024-03-15 |
BMRN |
BIOMARIN PHARMACEUTICAL INC |
Hardy Alexander |
CEO, Dir |
A - Grant |
$0.00 |
+32.8K |
148.2K |
+28% |
$0 |
| DM |
2023-12-05 |
2023-12-01 |
BMRN |
BIOMARIN PHARMACEUTICAL INC |
Hardy Alexander |
CEO, Dir |
A - Grant |
$0.00 |
+115.4K |
115.4K |
New |
$0 |